Medical - Care Facilities
Compare Stocks
4 / 10Stock Comparison
SNDA vs BKD vs ENSG vs SHC
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
Medical - Care Facilities
Medical - Diagnostics & Research
SNDA vs BKD vs ENSG vs SHC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Medical - Care Facilities | Medical - Care Facilities | Medical - Care Facilities | Medical - Diagnostics & Research |
| Market Cap | $695M | $3.22B | $10.18B | $4.47B |
| Revenue (TTM) | $381M | $3.11B | $5.27B | $1.19B |
| Net Income (TTM) | $-71M | $-205M | $363M | $118M |
| Gross Margin | -8.0% | 14.3% | 15.2% | 55.3% |
| Operating Margin | -15.3% | 1.4% | 8.5% | 34.9% |
| Forward P/E | — | — | 23.2x | 16.3x |
| Total Debt | $690M | $6.66B | $4.15B | $2.27B |
| Cash & Equiv. | $11M | $279M | $504M | $346M |
SNDA vs BKD vs ENSG vs SHC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 20 | May 26 | Return |
|---|---|---|---|
| Sonida Senior Livin… (SNDA) | 100 | 280.3 | +180.3% |
| Brookdale Senior Li… (BKD) | 100 | 319.7 | +219.7% |
| The Ensign Group, I… (ENSG) | 100 | 242.5 | +142.5% |
| Sotera Health Compa… (SHC) | 100 | 57.9 | -42.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SNDA vs BKD vs ENSG vs SHC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SNDA has the current edge in this matchup, primarily because of its strength in growth and dividends.
- 25.2% revenue growth vs BKD's 4.8%
- 0.9% yield, 1-year raise streak, vs ENSG's 0.1%, (2 stocks pay no dividend)
BKD is the clearest fit if your priority is momentum.
- +105.1% vs SHC's +19.2%
ENSG is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.
- Dividend streak 12 yrs, beta 0.42, yield 0.1%
- Rev growth 18.7%, EPS growth 14.1%, 3Y rev CAGR 18.7%
- 7.5% 10Y total return vs BKD's -26.0%
- Lower volatility, beta 0.42, current ratio 1.42x
SHC is the clearest fit if your priority is value and quality.
- Better valuation composite
- 9.9% margin vs SNDA's -18.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 25.2% revenue growth vs BKD's 4.8% | |
| Value | Better valuation composite | |
| Quality / Margins | 9.9% margin vs SNDA's -18.7% | |
| Stability / Safety | Beta 0.42 vs SHC's 1.32, lower leverage | |
| Dividends | 0.9% yield, 1-year raise streak, vs ENSG's 0.1%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +105.1% vs SHC's +19.2% | |
| Efficiency (ROA) | 6.8% ROA vs SNDA's -8.4%, ROIC 7.0% vs -5.8% |
SNDA vs BKD vs ENSG vs SHC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
SNDA vs BKD vs ENSG vs SHC — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
SHC leads in 2 of 6 categories
SNDA leads 0 • BKD leads 0 • ENSG leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
SHC leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ENSG is the larger business by revenue, generating $5.3B annually — 13.8x SNDA's $381M. SHC is the more profitable business, keeping 9.9% of every revenue dollar as net income compared to SNDA's -18.7%. On growth, ENSG holds the edge at +18.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $381M | $3.1B | $5.3B | $1.2B |
| EBITDAEarnings before interest/tax | -$1M | $384M | $558M | $517M |
| Net IncomeAfter-tax profit | -$71M | -$205M | $363M | $118M |
| Free Cash FlowCash after capex | -$9M | $56M | $406M | $112M |
| Gross MarginGross profit ÷ Revenue | -8.0% | +14.3% | +15.2% | +55.3% |
| Operating MarginEBIT ÷ Revenue | -15.3% | +1.4% | +8.5% | +34.9% |
| Net MarginNet income ÷ Revenue | -18.7% | -6.6% | +6.9% | +9.9% |
| FCF MarginFCF ÷ Revenue | -2.3% | +1.8% | +7.7% | +9.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.2% | -2.0% | +18.4% | +10.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -3.5% | +89.7% | +21.9% | +2.9% |
Valuation Metrics
Evenly matched — BKD and ENSG and SHC each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 29.8x trailing earnings, ENSG trades at a 49% valuation discount to SHC's 58.0x P/E. On an enterprise value basis, SHC's 21.1x EV/EBITDA is more attractive than ENSG's 25.7x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $695M | $3.2B | $10.2B | $4.5B |
| Enterprise ValueMkt cap + debt − cash | $1.4B | $9.6B | $13.8B | $6.4B |
| Trailing P/EPrice ÷ TTM EPS | -8.67x | -12.21x | 29.85x | 58.04x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 23.19x | 16.26x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 2.16x | — |
| EV / EBITDAEnterprise value multiple | — | 25.53x | 25.71x | 21.09x |
| Price / SalesMarket cap ÷ Revenue | 1.82x | 1.03x | 2.01x | 3.84x |
| Price / BookPrice ÷ Book value/share | 11.76x | — | 4.59x | 7.41x |
| Price / FCFMarket cap ÷ FCF | — | — | 27.46x | 29.95x |
Profitability & Efficiency
SHC leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
SHC delivers a 20.6% return on equity — every $100 of shareholder capital generates $21 in annual profit, vs $-235 for BKD. ENSG carries lower financial leverage with a 1.86x debt-to-equity ratio, signaling a more conservative balance sheet compared to SNDA's 12.26x. On the Piotroski fundamental quality scale (0–9), SHC scores 6/9 vs SNDA's 3/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -76.4% | -234.5% | +16.6% | +20.6% |
| ROA (TTM)Return on assets | -8.4% | -3.4% | +6.8% | +3.7% |
| ROICReturn on invested capital | -5.8% | +0.2% | +7.0% | +11.8% |
| ROCEReturn on capital employed | -7.7% | +0.3% | +10.2% | +13.3% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 4 | 5 | 6 |
| Debt / EquityFinancial leverage | 12.26x | — | 1.86x | 3.75x |
| Net DebtTotal debt minus cash | $679M | $6.4B | $3.7B | $1.9B |
| Cash & Equiv.Liquid assets | $11M | $279M | $504M | $346M |
| Total DebtShort + long-term debt | $690M | $6.7B | $4.2B | $2.3B |
| Interest CoverageEBIT ÷ Interest expense | -0.86x | 0.19x | 88.33x | 2.38x |
Total Returns (Dividends Reinvested)
Evenly matched — SNDA and BKD and ENSG each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ENSG five years ago would be worth $20,324 today (with dividends reinvested), compared to $6,367 for SHC. Over the past 12 months, BKD leads with a +105.1% total return vs SHC's +19.2%. The 3-year compound annual growth rate (CAGR) favors SNDA at 73.9% vs SHC's 1.5% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +14.6% | +25.0% | +0.3% | -11.4% |
| 1-Year ReturnPast 12 months | +52.7% | +105.1% | +27.5% | +19.2% |
| 3-Year ReturnCumulative with dividends | +426.3% | +239.7% | +88.9% | +4.6% |
| 5-Year ReturnCumulative with dividends | -23.8% | +85.2% | +103.2% | -36.3% |
| 10-Year ReturnCumulative with dividends | -87.7% | -26.0% | +752.0% | -37.6% |
| CAGR (3Y)Annualised 3-year return | +73.9% | +50.3% | +23.6% | +1.5% |
Risk & Volatility
Evenly matched — SNDA and ENSG each lead in 1 of 2 comparable metrics.
Risk & Volatility
ENSG is the less volatile stock with a 0.42 beta — it tends to amplify market swings less than SHC's 1.32 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SNDA currently trades 93.8% from its 52-week high vs SHC's 78.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.10x | 0.67x | 0.42x | 1.32x |
| 52-Week HighHighest price in past year | $38.98 | $17.00 | $218.00 | $19.85 |
| 52-Week LowLowest price in past year | $23.53 | $6.07 | $133.81 | $10.80 |
| % of 52W HighCurrent price vs 52-week peak | +93.8% | +79.7% | +80.0% | +78.9% |
| RSI (14)Momentum oscillator 0–100 | 63.5 | 54.0 | 23.3 | 56.5 |
| Avg Volume (50D)Average daily shares traded | 602K | 3.3M | 358K | 3.1M |
Analyst Outlook
Evenly matched — SNDA and ENSG each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: SNDA as "Hold", BKD as "Buy", ENSG as "Buy", SHC as "Buy". Consensus price targets imply 40.4% upside for SHC (target: $22) vs -5.2% for SNDA (target: $35). For income investors, SNDA offers the higher dividend yield at 0.85% vs ENSG's 0.14%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $34.67 | $17.67 | $222.33 | $22.00 |
| # AnalystsCovering analysts | 3 | 12 | 13 | 12 |
| Dividend YieldAnnual dividend ÷ price | +0.9% | — | +0.1% | — |
| Dividend StreakConsecutive years of raises | 1 | 0 | 12 | 2 |
| Dividend / ShareAnnual DPS | $0.31 | — | $0.24 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.2% | +0.2% | 0.0% |
SHC leads in 2 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 4 categories are tied.
SNDA vs BKD vs ENSG vs SHC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SNDA or BKD or ENSG or SHC a better buy right now?
For growth investors, Sonida Senior Living, Inc.
(SNDA) is the stronger pick with 25. 2% revenue growth year-over-year, versus 4. 8% for Brookdale Senior Living Inc. (BKD). The Ensign Group, Inc. (ENSG) offers the better valuation at 29. 8x trailing P/E (23. 2x forward), making it the more compelling value choice. Analysts rate Brookdale Senior Living Inc. (BKD) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SNDA or BKD or ENSG or SHC?
On trailing P/E, The Ensign Group, Inc.
(ENSG) is the cheapest at 29. 8x versus Sotera Health Company at 58. 0x. On forward P/E, Sotera Health Company is actually cheaper at 16. 3x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — SNDA or BKD or ENSG or SHC?
Over the past 5 years, The Ensign Group, Inc.
(ENSG) delivered a total return of +103. 2%, compared to -36. 3% for Sotera Health Company (SHC). Over 10 years, the gap is even starker: ENSG returned +752. 0% versus SNDA's -87. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SNDA or BKD or ENSG or SHC?
By beta (market sensitivity over 5 years), The Ensign Group, Inc.
(ENSG) is the lower-risk stock at 0. 42β versus Sotera Health Company's 1. 32β — meaning SHC is approximately 213% more volatile than ENSG relative to the S&P 500. On balance sheet safety, The Ensign Group, Inc. (ENSG) carries a lower debt/equity ratio of 186% versus 12% for Sonida Senior Living, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — SNDA or BKD or ENSG or SHC?
By revenue growth (latest reported year), Sonida Senior Living, Inc.
(SNDA) is pulling ahead at 25. 2% versus 4. 8% for Brookdale Senior Living Inc. (BKD). On earnings-per-share growth, the picture is similar: Sotera Health Company grew EPS 68. 8% year-over-year, compared to -681. 5% for Sonida Senior Living, Inc.. Over a 3-year CAGR, ENSG leads at 18. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SNDA or BKD or ENSG or SHC?
The Ensign Group, Inc.
(ENSG) is the more profitable company, earning 6. 8% net margin versus -20. 0% for Sonida Senior Living, Inc. — meaning it keeps 6. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SHC leads at 33. 8% versus -15. 3% for SNDA. At the gross margin level — before operating expenses — SHC leads at 55. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SNDA or BKD or ENSG or SHC more undervalued right now?
On forward earnings alone, Sotera Health Company (SHC) trades at 16.
3x forward P/E versus 23. 2x for The Ensign Group, Inc. — 6. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SHC: 40. 4% to $22. 00.
08Which pays a better dividend — SNDA or BKD or ENSG or SHC?
In this comparison, SNDA (0.
9% yield), ENSG (0. 1% yield) pay a dividend. BKD, SHC do not pay a meaningful dividend and should not be held primarily for income.
09Is SNDA or BKD or ENSG or SHC better for a retirement portfolio?
For long-horizon retirement investors, The Ensign Group, Inc.
(ENSG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 42), +752. 0% 10Y return). Both have compounded well over 10 years (ENSG: +752. 0%, SHC: -37. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SNDA and BKD and ENSG and SHC?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: SNDA is a small-cap high-growth stock; BKD is a small-cap quality compounder stock; ENSG is a mid-cap high-growth stock; SHC is a small-cap quality compounder stock. SNDA pays a dividend while BKD, ENSG, SHC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.